Bumpus Namandje
Reporting Owner SEC Filing List

CIK: 0002060594
FormFilerSubject CompanyFiling AgentDateActions
4Statement of changes in beneficial owner...Recursion Pharmaceuticals, Inc.06/22/2026
4Statement of changes in beneficial owner...Bumpus Namandje06/22/2026
4Statement of changes in beneficial owner...Recursion Pharmaceuticals, Inc.06/04/2026
4Statement of changes in beneficial owner...Bumpus Namandje06/04/2026
4Statement of changes in beneficial owner...Recursion Pharmaceuticals, Inc.Recursion Pharmaceuticals, Inc. /fa06/23/2025
4Statement of changes in beneficial owner...Bumpus NamandjeRecursion Pharmaceuticals, Inc. /fa06/23/2025
4Statement of changes in beneficial owner...Recursion Pharmaceuticals, Inc.Recursion Pharmaceuticals, Inc. /fa03/19/2025
3Initial statement of beneficial ownershi...Recursion Pharmaceuticals, Inc.Recursion Pharmaceuticals, Inc. /fa03/19/2025
4Statement of changes in beneficial owner...Bumpus NamandjeRecursion Pharmaceuticals, Inc. /fa03/19/2025
3Initial statement of beneficial ownershi...Bumpus NamandjeRecursion Pharmaceuticals, Inc. /fa03/19/2025

Bumpus Namandje 's Ownership Transactions

IssuerFiling
Date
Transaction
Date
Transaction
Type
SharesPriceTotal AmtShares Owned